BiotechTubeBiotechTube
Home/Cue Biopharma/Daniel Baker, M.D.
DB

Daniel Baker, M.D.

Interim Chief Development Officer

Cue Biopharma

Therapeutic Areas

Autoimmune DiseaseOncology

Cue Biopharma Pipeline

DrugIndicationPhase
CUE-101 / CUE-100 Series (representative)HPV+ Head and Neck Cancer / Solid TumorsPhase 1/2
Immuno-STAT Autoimmune ProgramAutoimmune Disease (undisclosed)Preclinical
Cell Therapy ApproachSolid TumorsDiscovery

Leadership Team at Cue Biopharma

U“
Usman “Oz” Azam, M.D.
President and Chief Executive Officer
LW
Lucinda Warren
Chief Financial Officer and Business Officer (CFBO)
View full Cue Biopharma profile